Sigyn Therapeutics SIGY
OTC SIGY
$0.03 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Sigyn Therapeutics (SIGY) EBITDA (2015 - 2025)

Updated

Sigyn Therapeutics (SIGY) posted EBITDA of -$266,790 for Q3 2025, compared with -$1.46 million a year earlier.

Analysis

Sigyn Therapeutics (SIGY) EBITDA (2015 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBITDA at Sigyn Therapeutics was -$1.62 million; for FY2024, it came in at -$2.98 million.

  • In prior years, Sigyn Therapeutics' EBITDA was -$4.2 million in FY2023, -$2.78 million in FY2022, -$2.36 million in FY2021 and -$1.18 million in FY2020.
  • The Q3 2025 figure stands as the highest quarterly EBITDA since Q2 2020.
  • According to Business Quant data, EBITDA for the three prior quarters was -$388,496 (Q2 2025), -$450,343 (Q1 2025) and -$516,734 (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -266,790.00
Jun 30, 2025 -388,496.00
Mar 31, 2025 -450,343.00
Dec 31, 2024 -516,734.00
Sep 30, 2024 -1.46 Mn
Jun 30, 2024 -459,168.00
Mar 31, 2024 -545,050.00
Dec 31, 2023 -1.16 Mn
Sep 30, 2023 -861,652.00
Jun 30, 2023 -868,535.00
Mar 31, 2023 -1.31 Mn
Dec 31, 2022 -806,049.00
Sep 30, 2022 -679,403.00
Jun 30, 2022 -638,773.00
Mar 31, 2022 -658,889.00
Dec 31, 2021 -670,186.00
Sep 30, 2021 -621,779.00
Jun 30, 2021 -623,047.00
Mar 31, 2021 -442,258.00
Dec 31, 2020 -399,401.00
API Access

Sigyn Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=SIGY&period=max&api_key=YOUR_API_KEY